- Home
- VTAK vs HSDT Comparison
VTAK vs HSDT Comparison
Compare VTAK & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- HSDT
- Stock Information
- Founded
- VTAK 2002
- HSDT N/A
- Country
- VTAK United States
- HSDT United States
- Employees
- VTAK N/A
- HSDT N/A
- Industry
- VTAK Medical/Dental Instruments
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VTAK Health Care
- HSDT Health Care
- Exchange
- VTAK Nasdaq
- HSDT Nasdaq
- Market Cap
- VTAK 3.1M
- HSDT 2.5M
- IPO Year
- VTAK 2018
- HSDT N/A
- Fundamental
- Price
- VTAK $0.24
- HSDT $8.43
- Analyst Decision
- VTAK
- HSDT Hold
- Analyst Count
- VTAK 0
- HSDT 1
- Target Price
- VTAK N/A
- HSDT N/A
- AVG Volume (30 Days)
- VTAK 41.3M
- HSDT 381.5K
- Earning Date
- VTAK 08-13-2025
- HSDT 08-11-2025
- Dividend Yield
- VTAK N/A
- HSDT N/A
- EPS Growth
- VTAK N/A
- HSDT N/A
- EPS
- VTAK N/A
- HSDT N/A
- Revenue
- VTAK $481,000.00
- HSDT $434,000.00
- Revenue This Year
- VTAK $822.86
- HSDT N/A
- Revenue Next Year
- VTAK $168.42
- HSDT $75.13
- P/E Ratio
- VTAK N/A
- HSDT N/A
- Revenue Growth
- VTAK 9.57
- HSDT N/A
- 52 Week Low
- VTAK $0.16
- HSDT $8.21
- 52 Week High
- VTAK $4.76
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- VTAK 45.34
- HSDT 21.23
- Support Level
- VTAK $0.22
- HSDT $8.21
- Resistance Level
- VTAK $0.25
- HSDT $10.70
- Average True Range (ATR)
- VTAK 0.02
- HSDT 1.81
- MACD
- VTAK -0.01
- HSDT 6.32
- Stochastic Oscillator
- VTAK 11.79
- HSDT 1.66
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.